| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.02. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.12.25 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 01.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 31.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.09.25 | IMAC Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 10.09.25 | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | 164 | GlobeNewswire (Europe) | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen | |
| 10.09.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,302 | -0,17 % | Plus Therapeutics Inc.: Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ | HOUSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 6,780 | 0,00 % | Lifeward Ltd.: Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors | IP and technology acquisition is expected to be highly accretive and to advance Lifeward's position as a diversified biomedical innovation companyWill Expand Lifeward's portfolio beyond lower-limb... ► Artikel lesen | |
| EKSO BIONICS | 10,230 | +1,39 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| IMUNON | 2,540 | +3,25 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,757 | -2,57 % | Why Is Rockwell Medical Gaining Tuesday? | ||
| VIRIDIAN THERAPEUTICS | 23,470 | -4,13 % | Viridian Therapeutics, Inc.\DE - S-8, Securities to be offered to employees in employee benefit plans | ||
| SINTX TECHNOLOGIES | 2,820 | 0,00 % | SiNtx Technologies, Inc.: SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstellung eines Siliziumnitrid-PEEK-Verbundwerkstoffes für KI-gestützte, 3D-gedruckte patientenspezifische Implantate | Ein Meilenstein, der die sofortige Produktion von maßgefertigten SiN/PEEK-Implantaten ermöglichtSALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX"... ► Artikel lesen | |
| AETHLON MEDICAL | 1,870 | -4,59 % | Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update | Clinical and research programs continue to advance, supported by year-to-date cost efficiencies
Conference Call Today at 4:30 p.m. ET
SAN DIEGO, Feb. 12, 2026 /PRNewswire/... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | ||
| NEURONETICS | 1,108 | 0,00 % | Neuronetics, Inc. - 8-K, Current Report | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 15-12G, Securities registration termination | ||
| HVIVO | 0,082 | -6,29 % | hVIVO PLC - Issue of Equity and Total Voting Rights | ||
| SIEMENS HEALTHINEERS | 41,370 | -1,83 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 50,78 | -0,24 % | Märkte am Morgen: Warner Bros-Übernahme, PayPal, AMC Entertainment, Fresenius, Jost Werke | Der DAX ist nach dem schwachen Handel am Montag auch gestern nicht in die Gänge gekommen. Letzten Endes ging der DAX 0,02 Prozent tiefer bei 24.986 Punkten aus dem Handel. Heute könnte er die Rückkehr... ► Artikel lesen |